Crossover to 689 nm laser therapy after poor responsiveness to subthreshold micropulse laser for chronic central serous chorioretinopathy
689 nm laser therapy provides the opportunity for cCSC eyes with poor responsiveness to SML treatment, especially when verteporfin is unavailable. There was also a notable recovery in the abnormal dilatation of choroidal vessels in the 689-LT group. Further studies are warranted to investigate the long-term efficacy and safety of 689 nm laser therapy in the management of cCSC.
Authors
- Xiaoya Gu
- Xiaobing Yu (ORCID: https://orcid.org/0000-0002-6797-063X)
- Shuang Song (ORCID: https://orcid.org/0000-0003-3681-8157)
- Jinrong Zhang (ORCID: https://orcid.org/0000-0003-0774-8479)
- Jianing Wang (ORCID: https://orcid.org/0000-0002-9294-2809)
- Yue Zhang (ORCID: https://orcid.org/0000-0002-3699-8736)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
Publication Details
- Journal
- Photodiagnosis and Photodynamic Therapy
- Published
- 2024-10-17
- DOI
- https://doi.org/10.1016/j.pdpdt.2024.104375
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Beijing Hospital